Front cover: Hypoglycemic activity of the Baker's yeast β‐glucan in obese/type 2 diabetic mice and the underlying mechanism

Mol. Nutr. Food Res. 2016, 60, 2678–2690. DOI: 10.1002/mnfr.201600032 The yeast β‐glucan (BYGlc) orally given to diet‐induced obese/type 2 diabetic mice improves hepatic glucose‐lipid homeostasis. BYGlc decreases blood glucose through inhibiting intestine SGLT‐1 expression, and alters the gut microbiota by increasing Akkermansia population, which may be associated with reduced inflammation.
Source: Nahrung / Food - Category: Nutrition Authors: Tags: Front Cover Source Type: research